Ogilvy CommonHealth Worldwide Featured in PharmaVOICE's Inaugural Innovation Issue

PARSIPPANY, NJ--(Marketwired - Apr 8, 2015) - Ogilvy CommonHealth Worldwide (www.ochww.com), the health behavior change experts of Ogilvy & Mather (www.ogilvy.com), and a WPP company (NASDAQ: WPPGY) (www.wpp.com), today announced the organization was selected by premier healthcare communications trade publication, PharmaVOICE, as one of the publication's inaugural inductees to their "Innovation Issue," released in April.

PharmaVOICE's "Innovation Issue" was created to recognize companies and organizations that are breaking new ground and changing the healthcare paradigm, as well as the products, tools, technologies, and processes that are making a difference in the lives of patients.

Ogilvy CommonHealth Worldwide is committed to creativity and effectiveness in healthcare communications, everywhere. Our global headquarters are in Parsippany, NJ, with additional hubs in New York, London, Paris and Singapore. We maintain multiple additional offices in markets critical to our clients' global aspirations. Ogilvy CommonHealth Worldwide provides marketing services including behavioral insights, content strategy and management, digital, interactive and new media services, marketing analytics and research, media planning and buying, medical education, payer marketing and market access, professional advertising and promotion, public affairs and relations, relationship marketing, sales training development, social media and social listening, and wellness and consumer advertising and promotion. The network also offers scientific communications and publications planning services through a wholly owned separate legal entity. The organization houses and maintains individual Ogilvy CommonHealth and Ogilvy Healthworld brand identities within the marketplace.